Valuation of Clinical Research Sites: What Buyers Look For in a Clinical Research Site Company
The clinical research site (CRS) sector has become one of the most active areas in life sciences M&A. With pharmaceutical companies accelerating development pipelines and competition for experienced trial sites intensifying, clinical research site businesses are increasingly viewed as strategic assets. For owners and operators, understanding the dynamics that influence valuation is essential to positioning […]